Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Alibaba Health Information Technology ( (HK:0241) ) has provided an announcement.
Alibaba Health Information Technology Limited has announced the granting of 3,515,900 Restricted Share Units (RSUs) to 50 employees under its 2024 Share Award Scheme. This move is part of the company’s strategy to incentivize its workforce, with the RSUs set to vest over a four-year period, reflecting a commitment to long-term growth and employee retention.
The most recent analyst rating on (HK:0241) stock is a Sell with a HK$4.60 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.
More about Alibaba Health Information Technology
Alibaba Health Information Technology Limited operates in the healthcare industry, focusing on digital healthcare services and products. The company is known for leveraging technology to enhance healthcare accessibility and efficiency, primarily in the Chinese market.
Average Trading Volume: 82,976,826
Technical Sentiment Signal: Hold
Current Market Cap: HK$86.18B
See more insights into 0241 stock on TipRanks’ Stock Analysis page.